← back to search

Pierluigi Bonomo

Leiden University Medical Center · IT
Area of research
Otorhinolaryngology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Head and Neck Cancer Studies, Advanced Radiotherapy Techniques, Oral health in cancer treatment, and Effects of Radiation Exposure.
h-index
34
citations
5,291
works
328
NIH funding
primary concept
Medicine
email

Recent publications

Outcomes of stereotactic body radiotherapy for bone oligometastases in older patients − A European multicenter cohort study
Radiotherapy and Oncology 2026cited by 1position: contributordoi
Late Toxicity and Long-Term Quality of Life in Survivors of Cancer of the Major Salivary Glands More Than 5 Years After Diagnosis: A Multi-National Study.
2026cited by 1position: contributordoi
Sequencing Immunotherapy and Hypofractionated Radiotherapy in Frail Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma.
2026cited by 0position: contributordoi
A prospective study with Comprehensive Geriatric Assessment (CGA) before curative treatment in older patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC)
Oral Oncology 2026cited by 0position: contributordoi
The Evolving Role of Radiation Therapy Technologists in Head and Neck Cancer: A Narrative Review and Operational Framework.
2026cited by 0position: contributordoi
Stereotactic body radiotherapy in patients with bone oligometastases from breast cancer – results from a European multicenter cohort study
Clinical and Translational Radiation Oncology 2026cited by 0position: contributordoi
Post-operative radiotherapy for oral cavity squamous cell carcinoma: Review of the data guiding the selection and the delineation of post-operative target volumes
Radiotherapy and Oncology 2025cited by 19position: middledoi
International consensus on laryngeal preservation strategies in laryngeal and hypopharyngeal cancer
The Lancet Oncology 2025cited by 14position: middledoi
Toxicities in long‐term survivors of head and neck cancer—A multi‐national cross‐sectional analysis
International Journal of Cancer 2025cited by 6position: middledoi
Shifting away from elective nodal irradiation in HNSCC: What do we know and Where are we heading?
2025cited by 1position: contributordoi
Patterns of care in de-novo oligo-metastatic and oligo-recurrent head and neck cancers: A Head and Neck Cancer International Group (HNCIG) Survey.
2025cited by 1position: contributordoi
Delineation of the post-operative primary tumour and nodal clinical target volumes in oral cavity squamous cell carcinoma: European Society for Radiotherapy and Oncology (ESTRO) clinical guidelines
Radiotherapy and Oncology 2025cited by 1position: contributordoi
Patient experience and shared decision-making in HPV-positive oropharyngeal cancer: A systematic review of qualitative and quantitative evidence.
2025cited by 0position: contributordoi
Deglutition preservation after swallowing (SWOARs)-sparing IMRT in head and neck cancers: definitive results of a multicenter prospective study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
2025cited by 0position: contributordoi
Perineural invasion and parotid involvement in auricular cutaneous SCC: Which volumes to treat in postoperative radiotherapy?
2025cited by 0position: contributordoi
Stereotactic Salvage Radiotherapy for Macroscopic Prostate Bed Recurrence After Prostatectomy: STARR (NCT05455736): An Early Analysis from the STARR Trial
Cancers 2025cited by 0position: contributordoi
Long‐term health‐related quality of life in head and neck cancer survivors: A large multinational study
International Journal of Cancer 2024cited by 39position: middledoi
MASCC/ISOO Clinical Practice Statement: Management of salivary gland hypofunction and xerostomia in cancer patients
Supportive Care in Cancer 2024cited by 18position: middledoi
Guidance on mucositis assessment from the MASCC Mucositis Study Group and ISOO: an international Delphi study
EClinicalMedicine 2024cited by 15position: middledoi
Open-Face Masks in Radiotherapy: Enhancing Therapeutic Strategies for Head and Neck and Brain Cancer Patients-A Comprehensive Scoping Review.
2024cited by 6position: contributordoi
The european organisation for research and treatment of cancer head and neck cancer module (EORTC QLQ-HN43): Estimates for minimal important difference and minimal important change
European Journal of Cancer 2024cited by 5position: middledoi
Recent Advances and Current Challenges in Stereotactic Body Radiotherapy for Ultra-Central Lung Tumors.
2024cited by 2position: contributordoi
Prophylactic Radiation Therapy for High-Risk Asymptomatic Bone Metastases: A New Standard of Care or Need for More Data?
2024cited by 2position: contributordoi
Editorial: Diagnosis, epidemiology and treatment of salivary gland carcinomas
Frontiers in Oncology 2024cited by 1position: middledoi
Recent Advances and Current Challenges in Stereotactic Body Radiotherapy for Ultra-Central Lung Tumors
2024cited by 0position: contributordoi
Stereotactic body radiation therapy versus conventional external beam radiotherapy for spinal metastases: A systematic review and meta-analysis of randomized controlled trials
Radiotherapy and Oncology 2023cited by 35position: middledoi
Serious Long-Term Effects of Head and Neck Cancer from the Survivors’ Point of View
Healthcare 2023cited by 35position: middledoi
Diagnostic challenges and prognostic implications of extranodal extension in head and neck cancer: a state of the art review and gap analysis
Frontiers in Oncology 2023cited by 31position: middledoi
Serious Long-Term Effects of Head and Neck Cancer from the Survivors' Point of View.
2023cited by 25position: contributordoi
Barrier Films and Dressings for the Prevention of Acute Radiation Dermatitis: A Systematic Review and Meta-Analysis.
2023cited by 16position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 18 papers (2019–2026)Isacco Desideri · IRCCS Humanitas Research Hospital13 papers (2019–2026)Paolo Bossi · University of Hong Kong7 papers (2020–2026)Ester Orlandi · National Center for Oncological Hadrontherapy6 papers (2019–2024)Susanne Singer · University Medical Center Freiburg4 papers (2020–2026)Vincent Grégoire · Centre de Recherche en Cancérologie de Lyon3 papers (2025–2025) · 3 papers (2020–2026)Alexander Rühle · Leipzig University of Applied Sciences3 papers (2025–2026)Daniel Zips · Auguste-Viktoria-Klinik3 papers (2017–2020)Michele Fiore · Università Campus Bio-Medico3 papers (2015–2023)Cihan Gani · German Cancer Research Center3 papers (2017–2020) · 2 papers (2020–2023)Charles B. Simone · Novartis (United States)2 papers (2023–2024)Gabriella Macchia · Istituti di Ricovero e Cura a Carattere Scientifico2 papers (2020–2023) · 2 papers (2020–2023)Francesco Cellini · Università Campus Bio-Medico2 papers (2020–2023)Melvin L.K. Chua · National Cancer Centre Singapore2 papers (2025–2025) · 2 papers (2020–2023)Sue S. Yom · UCSF Helen Diller Family Comprehensive Cancer Center2 papers (2025–2025) · 2 papers (2026–2026)